Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model

被引:6
作者
Bikou, Olympia [1 ]
Hajjar, Roger J. [2 ]
Hadri, Lahouaria [1 ]
Sassi, Yassine [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA
[2] Phospholamban Fdn, New York, NY USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2020年 / 160期
基金
美国国家卫生研究院;
关键词
Medicine; Issue; 160; Hypoxia; SU5416; Sugen; pulmonary hypertension; PH; right ventricular pressure; pulmonary vascular remodeling; right ventricular remodeling; 5416/HYPOXIA MOUSE MODEL; ARTERIAL-HYPERTENSION; ANIMAL-MODELS;
D O I
10.3791/59252
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pulmonary Hypertension (PH) is a pathophysiological condition, defined by a mean pulmonary arterial pressure exceeding 25 mm Hg at rest, as assessed by right heart catheterization. A broad spectrum of diseases can lead to PH, differing in their etiology, histopathology, clinical presentation, prognosis, and response to treatment. Despite significant progress in the last years, PH remains an uncured disease. Understanding the underlying mechanisms can pave the way for the development of new therapies. Animal models are important research tools to achieve this goal. Currently, there are several models available for recapitulating PH. This protocol describes a two-hit mouse PH model. The stimuli for PH development are hypoxia and the injection of SU5416, a vascular endothelial growth factor (VEGF) receptor antagonist. Three weeks after initiation of Hypoxia/SU5416, animals develop pulmonary vascular remodeling imitating the histopathological changes observed in human PH (predominantly Group 1). Vascular remodeling in the pulmonary circulation results in the remodeling of the right ventricle (RV). The procedures for measuring RV pressures (using the open chest method), the morphometrical analyses of the RV (by dissecting and weighing both cardiac ventricles) and the histological assessments of the remodeling (both pulmonary by assessing vascular remodeling and cardiac by assessing RV cardiomyocyte hypertrophy and fibrosis) are described in detail. The advantages of this protocol are the possibility of the application both in wild type and in genetically modified mice, the relatively easy and low-cost implementation, and the quick development of the disease of interest (3 weeks). Limitations of this method are that mice do not develop a severe phenotype and PH is reversible upon return to normoxia. Prevention, as well as therapy studies, can easily be implemented in this model, without the necessity of advanced skills (as opposed to surgical rodent models).
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] The p110α[[Unable to Display Character: &]]Selective PI3K Inhibitor PIK75 Reverses SU5416/Hypoxia-Induced PH
    Berghausen, Eva M.
    Behringer, Arnica
    Vantler, Marius
    Baldus, Stephan
    Rosenkranz, Stephan
    CIRCULATION, 2014, 130
  • [42] Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension
    Gadkari, Mahin
    Philip, Nicolas
    Zhang, Cissy
    Huetsch, John
    Yun, Xin
    Harlan, Robert
    Graham, David
    Shimoda, Larissa
    Le, Anne
    Simpson, Catherine
    Santhanam, Lakshmi
    Visovatti, Scott
    Steppan, Jochen
    Suresh, Karthik
    PHYSIOLOGY, 2023, 38
  • [43] Levosimendan Attenuates Hypoxia-Induced Pulmonary Hypertension in a Porcine Model
    Wiklund, Annaeva
    Kylhammar, David
    Radegran, Goran
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 59 (05) : 441 - 449
  • [44] Smooth Muscle Cell-Specific LKB1 Protects Against Sugen 5416/Hypoxia-induced Pulmonary Hypertension through Inhibition of BMP4
    Liu, Yan
    Ma, Xiaoping
    Lei, Lingli
    Wang, Lin
    Deng, Qiming
    Lu, Hanlin
    Li, Hongxuan
    Tian, Shuhui
    Qin, Xiaoteng
    Zhang, Wencheng
    Sun, Yuanyuan
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2025, 72 (02) : 169 - 180
  • [45] Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice
    Tian, Qiuyun
    Fan, Xiaofang
    Ma, Jianshe
    Li, Dantong
    Han, Yujiao
    Yin, Xianghong
    Wang, Hui
    Huang, Tingting
    Wang, Zhenglu
    Shentu, Yangping
    Xue, Feng
    Du, Congkuo
    Wang, Yongyu
    Mao, Sunzhong
    Fan, Junming
    Gong, Yongsheng
    FASEB JOURNAL, 2021, 35 (08)
  • [46] High-fat diet attenuates the improvement of hypoxia-induced pulmonary hypertension in mice during reoxygenation
    Sugimoto, Koichi
    Yokokawa, Tetsuro
    Misaka, Tomofumi
    Kaneshiro, Takashi
    Yoshihisa, Akiomi
    Nakazato, Kazuhiko
    Takeishi, Yasuchika
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [47] Detection and characterization of long noncoding RNAs in hypoxia-induced pulmonary hypertension
    Brock, Matthias
    Schuoler, Claudio
    Haider, Thomas
    Ulrich, Silvia
    Gassmann, Max
    Kohler, Malcolm
    Huber, Lars
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [48] Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
    Balram Neupane
    Akylbek Sydykov
    Kabita Pradhan
    Christina Vroom
    Christiane Herden
    Srikanth Karnati
    Hossein Ardeschir Ghofrani
    Sergey Avdeev
    Süleyman Ergün
    Ralph Theo Schermuly
    Djuro Kosanovic
    Respiratory Research, 21
  • [49] Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension
    Fagan K.A.
    Morrissey B.
    Fouty B.W.
    Sato K.
    Harral J.W.
    Morris Jr. K.G.
    Hoedt-Miller M.
    Vidmar S.
    McMurtry I.F.
    Rodman D.M.
    Respiratory Research, 2 (5) : 306 - 313
  • [50] The Role of NADPH Oxidase in Chronic Intermittent Hypoxia-Induced Pulmonary Hypertension in Mice
    Nisbet, Rachel E.
    Graves, Anitra S.
    Kleinhenz, Dean J.
    Rupnow, Heidi L.
    Reed, Alana L.
    Fan, Tai-Hwang M.
    Mitchell, Patrick O.
    Sutliff, Roy L.
    Hart, C. Michael
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2009, 40 (05) : 601 - 609